52
Participants
Start Date
November 15, 2022
Primary Completion Date
July 5, 2023
Study Completion Date
July 5, 2023
mesofiller® mesotox
The investigated product mesofiller® mesotox was applied by intradermal or subcutaneous injection by the investigator during Session 1 for all subjects and Session 2 for the subjects, for whom a touch-up was considered beneficial. Both sessions were conducted within 14-day intervals.
"Medical Center Ramus EOOD", Sofia
Mesoestetic Pharma Group S.L.
INDUSTRY